These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

715 related items for PubMed ID: 19953334

  • 1. Prognostic factors influencing long-term survival of patients undergoing nephron-sparing surgery for nonmetastatic renal-cell carcinoma (RCC) with imperative indications.
    Haferkamp A, Kurosch M, Pritsch M, Hatiboglu G, Macher-Goeppinger S, Pfitzenmaier J, Pahernik S, Wagener N, Hohenfellner M.
    Ann Surg Oncol; 2010 Feb; 17(2):544-51. PubMed ID: 19953334
    [Abstract] [Full Text] [Related]

  • 2. Elective nephron sparing surgery should become standard treatment for small unilateral renal cell carcinoma: Long-term survival data of 216 patients.
    Becker F, Siemer S, Humke U, Hack M, Ziegler M, Stöckle M.
    Eur Urol; 2006 Feb; 49(2):308-13. PubMed ID: 16359779
    [Abstract] [Full Text] [Related]

  • 3. Bilateral synchronous sporadic renal cell carcinoma: surgical management, oncological and functional outcomes.
    Pahernik S, Cudovic D, Roos F, Melchior SW, Thüroff JW.
    BJU Int; 2007 Jul; 100(1):26-9. PubMed ID: 17552949
    [Abstract] [Full Text] [Related]

  • 4. Outcome of nephron-sparing surgery for T1b renal cell carcinoma.
    Joniau S, Vander Eeckt K, Srirangam SJ, Van Poppel H.
    BJU Int; 2009 May; 103(10):1344-8. PubMed ID: 19040528
    [Abstract] [Full Text] [Related]

  • 5. The effect of bilaterality, pathological features and surgical outcome in nonhereditary renal cell carcinoma.
    Blute ML, Itano NB, Cheville JC, Weaver AL, Lohse CM, Zincke H.
    J Urol; 2003 Apr; 169(4):1276-81. PubMed ID: 12629342
    [Abstract] [Full Text] [Related]

  • 6. Positive surgical margin appears to have negligible impact on survival of renal cell carcinomas treated by nephron-sparing surgery.
    Bensalah K, Pantuck AJ, Rioux-Leclercq N, Thuret R, Montorsi F, Karakiewicz PI, Mottet N, Zini L, Bertini R, Salomon L, Villers A, Soulie M, Bellec L, Rischmann P, De la Taille A, Avakian R, Crepel M, Ferriere JM, Bernhard JC, Dujardin T, Pouliot F, Rigaud J, Pfister C, Albouy B, Guy L, Joniau S, van Poppel H, Lebret T, Culty T, Saint F, Zisman A, Raz O, Lang H, Spie R, Wille A, Roigas J, Aguilera A, Rambeaud B, Martinez Piñeiro L, Nativ O, Farfara R, Richard F, Roupret M, Doehn C, Bastian PJ, Muller SC, Tostain J, Belldegrun AS, Patard JJ.
    Eur Urol; 2010 Mar; 57(3):466-71. PubMed ID: 19359089
    [Abstract] [Full Text] [Related]

  • 7. Multiple ipsilateral renal tumors discovered at planned nephron sparing surgery: importance of tumor histology and risk of metachronous recurrence.
    Blute M, Thibault GP, Leibovich BC, Cheville JC, Lohse CM, Zincke H.
    J Urol; 2003 Sep; 170(3):760-3. PubMed ID: 12913692
    [Abstract] [Full Text] [Related]

  • 8. Disease outcome in patients with low stage renal cell carcinoma treated with nephron sparing or radical surgery.
    Lerner SE, Hawkins CA, Blute ML, Grabner A, Wollan PC, Eickholt JT, Zincke H.
    J Urol; 1996 Jun; 155(6):1868-73. PubMed ID: 8618276
    [Abstract] [Full Text] [Related]

  • 9. Long-term survival of patients with unilateral sporadic multifocal renal cell carcinoma according to histologic subtype compared with patients with solitary tumors after radical nephrectomy.
    Dimarco DS, Lohse CM, Zincke H, Cheville JC, Blute ML.
    Urology; 2004 Sep; 64(3):462-7. PubMed ID: 15351571
    [Abstract] [Full Text] [Related]

  • 10. Long-term outcomes after nephron sparing surgery for renal cell carcinoma larger than 4 cm.
    Peycelon M, Hupertan V, Comperat E, Renard-Penna R, Vaessen C, Conort P, Bitker MO, Chartier-Kastler E, Richard F, Rouprêt M.
    J Urol; 2009 Jan; 181(1):35-41. PubMed ID: 19012929
    [Abstract] [Full Text] [Related]

  • 11. Oncological efficacy and safety of nephron-sparing surgery for selected patients with locally advanced renal cell carcinoma.
    Margulis V, Tamboli P, Jacobsohn KM, Swanson DA, Wood CG.
    BJU Int; 2007 Dec; 100(6):1235-9. PubMed ID: 17979923
    [Abstract] [Full Text] [Related]

  • 12. pT1 clear cell renal cell carcinoma: a study of the association between MIB-1 proliferative activity and pathologic features and cancer specific survival.
    Cheville JC, Zincke H, Lohse CM, Sebo TJ, Riehle D, Weaver AL, Blute ML.
    Cancer; 2002 Apr 15; 94(8):2180-4. PubMed ID: 12001115
    [Abstract] [Full Text] [Related]

  • 13. The influence of body mass index on the long-term survival of patients with renal cell carcinoma after tumour nephrectomy.
    Haferkamp A, Pritsch M, Bedke J, Wagener N, Pfitzenmaier J, Buse S, Hohenfellner M.
    BJU Int; 2008 May 15; 101(10):1243-6. PubMed ID: 18261150
    [Abstract] [Full Text] [Related]

  • 14. Application of TNM, 2002 version, in localized renal cell carcinoma: is it able to predict different cancer-specific survival probability?
    Ficarra V, Novara G, Galfano A, Novella G, Schiavone D, Artibani W.
    Urology; 2004 Jun 15; 63(6):1050-4. PubMed ID: 15183948
    [Abstract] [Full Text] [Related]

  • 15. Nephron sparing surgery for appropriately selected renal cell carcinoma between 4 and 7 cm results in outcome similar to radical nephrectomy.
    Leibovich BC, Blute M, Cheville JC, Lohse CM, Weaver AL, Zincke H.
    J Urol; 2004 Mar 15; 171(3):1066-70. PubMed ID: 14767272
    [Abstract] [Full Text] [Related]

  • 16. The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma.
    Ward JF, Blute ML, Cheville JC, Lohse CM, Weaver AL, Zincke H.
    J Urol; 2002 Jul 15; 168(1):56-60. PubMed ID: 12050492
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of renicapsular involvement in Stages I and II renal cell carcinoma from the morphological and prognostic point of view.
    May M, Brookman-Amissah S, Roigas J, Gilfrich CP, Pflanz S, Hoschke B, Gunia S.
    Urol Oncol; 2010 Jul 15; 28(3):274-9. PubMed ID: 18805709
    [Abstract] [Full Text] [Related]

  • 18. Prognostic value of microscopic venous invasion in renal cell carcinoma: long-term follow-up.
    Lang H, Lindner V, Letourneux H, Martin M, Saussine C, Jacqmin D.
    Eur Urol; 2004 Sep 15; 46(3):331-5. PubMed ID: 15306103
    [Abstract] [Full Text] [Related]

  • 19. Prognosticfactors in patients with renal cell carcinoma: is TNM (1997) staging relevant in Indian subpopulation?
    Srivastava A, Mandhani A, Kapoor R, Jain M, Dubey D, Srivastava A, Raghavendra M, Kumar A.
    Indian J Cancer; 2004 Sep 15; 41(3):99-103. PubMed ID: 15472406
    [Abstract] [Full Text] [Related]

  • 20. Clinicopathological features and prognosis of synchronous bilateral renal cell carcinoma: an international multicentre experience.
    Klatte T, Wunderlich H, Patard JJ, Kleid MD, Lam JS, Junker K, Schubert J, Böhm M, Allhoff EP, Kabbinavar FF, Crepel M, Cindolo L, De La Taille A, Tostain J, Mejean A, Soulie M, Bellec L, Bernhard JC, Ferriere JM, Pfister C, Albouy B, Colombel M, Zisman A, Belldegrun AS, Pantuck AJ.
    BJU Int; 2007 Jul 15; 100(1):21-5. PubMed ID: 17433034
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.